Frantzi, Maria
Gomez Gomez, Enrique
Blanca Pedregosa, Ana
Valero Rosa, José
Latosinska, Agnieszka
Culig, Zoran
Merseburger, Axel S.
Luque, Raul M.
Requena Tapia, María José
Mischak, Harald
Carrasco Valiente, Julia
Article History
Received: 6 October 2018
Revised: 11 April 2019
Accepted: 16 April 2019
First Online: 16 May 2019
Competing interests
: H.M. is the founder and co-owner of Mosaiques Diagnostics. M.F. and A.L. are employed by Mosaiques Diagnostics.
: This work was supported by The Spanish Ministerio de Economía y Competitividad (MINECO) and FEDER programme which are gratefully acknowledged for the financial support (Projects “Development of methods for early cancer detection; ONCOVER—detection system of volatile compounds for early diagnosis of lung, colon and prostate cancer”, CCB.030PM). This research was also supported in part by the BioGuidePCa (E! 11023, Eurostars) funded by BMBF (Germany) and PCaProTreat (H2020-MSCA-IF-2017-800048).
: This study was performed as part of the ONCOVER project. Ethical approval was obtained by the Reina Sofia Hospital Research Ethics Committee in accordance with the Declaration of Helsinki and informed consent was obtained from all participants for the project.
: All data generated or analysed during this study are included in this published article.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).